Anal fistula (fistula-in-ano)
fistula · GI / Surgical
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An abnormal track between the anal canal and perianal skin, usually arising from a previous cryptoglandular abscess. Goals are to drain sepsis, define anatomy relative to the sphincter complex and eradicate the track while preserving continence.
Red flags
- Spreading perianal sepsis / necrotising infection
- Immunosuppression or diabetes with uncontrolled sepsis
- Induration or mass suggesting malignancy
- Multiple complex tracks suggesting Crohn's
- Faecal incontinence after prior surgery
Assessment
Differential diagnosis
- Cryptoglandular fistula-in-ano
- Crohn's perianal fistula
- Hidradenitis suppurativa
- Pilonidal sinus
- Perianal abscess
- Anal/rectal malignancy
- Tuberculous or actinomycotic fistula
Investigations
- Examination and rigid proctoscopy under anaesthesia (EUA)
- MRI pelvis for complex, recurrent or Crohn's-associated fistulae
- Endoanal ultrasound as alternative imaging
- Colonoscopy / small bowel assessment if Crohn's suspected
- Biopsy of atypical tracks to exclude malignancy
- FBC, CRP, HbA1c; faecal calprotectin if IBD suspected
Management
- Drain any associated acute abscess first
- Perform EUA to define internal/external openings and the track relative to sphincters (Parks classification)
- Apply Goodsall's rule as a guide to track orientation
- Classify as intersphincteric, transsphincteric, suprasphincteric or extrasphincteric
- For simple low fistulae consider fistulotomy (lay-open) with minimal sphincter division
- For high/complex fistulae place a loose draining seton to control sepsis and preserve continence
- Plan definitive sphincter-preserving procedures (LIFT, advancement flap, fistula plug) for complex tracks
- Investigate and co-manage underlying Crohn's disease with gastroenterology
- Counsel carefully on continence risk before any sphincter division
- Provide wound care and follow-up after surgery
- Consider biologic therapy for refractory Crohn's fistulae
- Safety-net for recurrent sepsis and recurrence
Drugs & doses
Metronidazole 400 mg PO TDS (adjunct, especially Crohn's)
Ciprofloxacin 500 mg PO BD for Crohn's perianal disease
Paracetamol 1 g PO QDS
Stool softener (e.g. lactulose 15 mL BD) to ease post-op defecation
Anti-TNF biologic (e.g. infliximab) for complex Crohn's fistula per gastroenterology
Disposition
Elective colorectal surgical referral for EUA and definitive management; urgent admission for associated acute perianal sepsis. Co-refer suspected Crohn's to gastroenterology.
Complications & pitfalls
- Faecal incontinence from sphincter division
- Recurrence or persistence
- Chronic non-healing wound
- Progression of undiagnosed Crohn's
- Rare malignant transformation
Exam pearls
- Never divide significant sphincter muscle in high transsphincteric fistulae — use a seton and sphincter-preserving techniques
- MRI is the gold standard for mapping complex and recurrent fistulae
- Suspect Crohn's with multiple, complex or recurrent fistulae — investigate the whole gut
- Goodsall's rule guides but does not replace operative assessment of track anatomy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.